Your browser doesn't support javascript.
loading
HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome.
He, Xiaoting; Wang, Huiyu; Wang, Runjie; Li, Yuting; Li, Suqing; Cao, Xiufeng; Xu, Junying.
Afiliação
  • He X; Oncology Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, China.
  • Wang H; Oncology Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, China.
  • Wang R; Oncology Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, China.
  • Li Y; Oncology Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, China.
  • Li S; General Surgery Department, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210012, China.
  • Cao X; General Surgery Department, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210012, China.
  • Xu J; Oncology Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, China.
Heliyon ; 9(10): e21056, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37876483

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article